Evaluation of clinical, laboratorial and ultrasonographic predicting factors of malignancy in thyroid nodules;Avaliação de fatores clínicos, laboratoriais e ultrassonográficos preditores de malignidade em nódulos tiroidianos

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 55, Issue 1, 2011, Pages 29-37

  Rio, Ana Luiza Silva ^a,b   Biscolla, Rosa Paula Mello ^a,b,c   Andreoni, Danielle Macellaro ^a,b   Camacho, Cléber Pinto ^a,b   Nackabashi, Cläudia Cristina Doimo ^a,b   de Oliveira Carneiro Mamone, Maria Conceï̈o ^a,b   Ikejiri, Elza Setsuku ^a,b   Matsumura, Luiza K ^a,b   Hidal, Jairo Tabacow ^a,b   de Maciel, Rui Monteiro Barros ^a,b,c   Furlanetto, Reinaldo Perrone ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c Fleury   (Brazil)

Author keywords

Age; Fine needle aspiration biopsy; Male sex; Thyroid nodules; Ultrasonography

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CALCINOSIS; CARCINOMA; CHILD; ECHOGRAPHY; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; THYROID GLAND; THYROID NODULE; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CALCINOSIS; CARCINOMA; CHILD; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; YOUNG ADULT;

EID: 79954500162     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302011000100004     Document Type: Article

References (39)

1. Wiest PW, Hartshome MF, Inskip PD, Crooks LA, Vela BS, Telepak RJ, et al. Thyroid palpation versus high-resolution thyroid ultrasonography in the detection of nodules. J Ultrasound Med. 1998;17(8):487-96.
2. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16(2):1-24.
3. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126(3):226-31.
4. Hegedüs L. The thyroid nodule. N Eng J Med. 2004;351(17):1764-71.
5. Hegedüs L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Ver. 2003;24(1):102-32.
6. Lloyd R, De Lellis R, Heitz P, Eng C. World Health Organization: pathologic and genetics of tumors of endocrine organs. Lyon, França: IARC Press International Agency for Research on Cancer; 2004.
7. Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006;91(9):3411-7.
8. Shibata Y, Yamashita S, Masyakin VB, Panasyuk GD, Nagataki S. 15 years after Chernobyl: new evidence of thyroid cancer. Lancet. 2001;358(9297):1965-6.
9. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab. 2006;91(11):4295-301.
10. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993;328(8):553-9.
11. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age and multinodularity. Am J Med. 1992;93(4):363-9.
12. Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES, et al. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med. 2000;133(9):696-700.
13. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, et al. Higher serum TSH level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab. 2008;93(3):809-14.
14. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab. 2002;87(5):1941-6.
15. Nam-Goong IS, Kim HY, Gong G, Lee HK, Hong SJ, Kim WB, et al. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol. 2004;60(1):21-8.
16. Rago T, Vitti P, Chiovato SM, Mazzeo S, DeLiperi A, Miccolo P, et al. Role of conventional ultrasonography and color flow-Doppler sonography in predicting malignancy in "cold" thyroid nodules. Eur J Endocrinol. 1998;138(1):41-6.
17. Maia AL, Ward LS, Carvalho GA, Graf H, Maciel RMB, Maciel LMZ, et al. Nódulos de tireóide e câncer diferenciado de tireóide: consenso brasileiro. Arq Bras Endocrinol Metab. 2007;51(5):867-93.
18. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154(6):787-803.
19. Castro MR, Gharib H. Continuing controversies in the management of thyroid nodules. Ann Intern Med. 2005;142(11):926-31.
20. Kratzsch J, Fiedler GM, Leichtle A, Brügel M, Buchbinder S, Otto L, et al. New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem. 2005;51(8):1480-6.
21. Hollowell JG, Staehling NW, Flanders D, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T4 and thyroid antibodies in The United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-99.
22. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228-38.
23. Alexander EK. Approach to the patient with a cytologically indeterminate thyroid nodule. J Clin Endocrinol Metab. 2008;93(11):4175-82.
24. Banks ND, Kowalski J, Tsai HL, Somervell H, Tufano R, Dackiw APB, et al. A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid. 2008;18(9):933-41.
25. Goldstein RE, Burkey B, Johnson JE. Implications of follicular neoplasms, atypia and lesions suspicious of malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg. 2002;235(5):656-64.
26. Kelman AS, Leibowitz J, Burstein DE, Haber RS. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens. Thyroid. 2001;11(3):271-7.
27. Layfield LJ, Cibas ES, Gharib H, Mandel SJ. Thyroid aspiration cytology. Current Status. Cancer J Clin. 2009;59:99-110.
28. Roti E, Uberti EC, Bondanelli M, Braverman LE. Thyroid papillary microcarcinoma: a descriptive meta-analysis study. Eur J Endocrinol. 2008;159(6):656-73.
29. Leenhardt L, Grosclaude P, Chérié-Challine L. Thyroid Cancer Committee. Increase incidence of thyroid carcinoma in France: a true epidemic of thyroid nodule managements effect? Thyroid. 2004;14(12):1056-106.
30. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-214.
31. Rago T, Fiore E, Scutari M, Santini F, Di Coscio G, Romani R, et al. Cytology suspicious for or indicative of PTC is associated with younger age, male sex, and solitary versus multiple nodularity. Eur J Endocrinol. 2010;162:763-70.
32. Matsuo K, Friedman E, Gejman PV, Fagin JA. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the α-subunit of Gs in human thyroid neoplasms. J Clin Endocrinol Metab. 1993;76(6):1446-51.
33. Derwahl M, Broecker M, Kraiem Z. Thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors. J Clin Endocrinol Metab. 1999;84(3):829-34.
34. Mazzaferri EL. Thyroid cancer and Graves disease: the controversy ten years later. Endocr Pract. 2000;6(2):221-5.
35. Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Bierley JD, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid. 2006;16(12):1229-42.
36. Akinci M, Kosova F, Cetin B, Aslan S, Ari Z, Cetin A. Leptin levels in thyroid cancer. Asian J Surg. 2009;32(4):216-23.
37. Paes JE, Hua K, Nagy R, Kloos RT, Jarioura D, Ringel MD. The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. J Clin Endocrinol Metab. 2010;95(9):4244-50.
38. Rezzónico JN, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H. Increases prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord. 2009;7(4):375-80.
39. Pasieka JL. Hashimoto's disease and thyroid lymphoma: role of the surgeon. World J Surg. 2000;24(8):966-70.